期刊文献+

华蟾素联合顺铂对人骨肉瘤U2OS细胞增殖和凋亡的影响 被引量:5

Effect of Cinobufacini plus Cisplatin on the Proliferation and Apoptosis of Osteosarcoma U2OS Cells
原文传递
导出
摘要 目的:研究华蟾素联合顺铂对人骨肉瘤U2OS细胞增殖和凋亡的影响,并探寻联合治疗增敏的可能分子机制。方法:采用不同浓度的华蟾素、顺铂单药和华蟾素联合顺铂处理人骨肉瘤U2OS细胞1-3天,通过CCK-8法检测其对U2OS细胞生长的抑制作用;平板克隆实验检测其对U2OS细胞集落形成能力的影响;流式细胞仪检测其对U2OS细胞凋亡的影响;RT-PCR及Western blotting检测Bax、Bcl-2、caspase-3、caspase-9等凋亡相关分子mRNA及蛋白水平的表达。结果:单用华蟾素或顺铂均可以浓度和时间依赖的方式抑制骨肉瘤U2OS细胞的增殖并诱导其凋亡,两药联合应用具有协同效应,并可以上调促凋亡基因Bax下调抑制凋亡基因Bcl-2的表达;联合用药组凋亡相关蛋白caspase-3、caspase-9的表达较单药组明显增加。结论:华蟾素联合顺铂与单一用药相比能够显著抑制人骨肉瘤细胞U2OS细胞的增殖,促进其凋亡,两药联合应用对骨肉瘤细胞的杀伤效应具有一定的协同效应,其机制可能与激活凋亡通路有关。 Objective: To explore the effect of Cinobufacini plus Cisplatin (CDDP) on the proliferation and apoptosis of U2OS cell line, and explore the possible molecular mechanism of combination therapy. Methods: U2OS cells were treated with different concentrations of Cinobufacini and CDDP or in combination for one to three days. The proliferation of U2OS was tested by CCK-8 assay. The clonatity of U2OS was assessed by clone formation assay. The cell apoptosis was detected by flow cytometer. The expression of apoptosis related genes and proteins was detected by RT-PCR and Western blot. Results: Cinobufacini or CDDP could inhibit the proliferation and induce the apoptosis of U2OS cells in a dose- and time-dependent manner. However, combination of two drugs could inhibit the cell clone formation and markedly promote the cell apoptosis. Combination of two drugs had synergistic effect on the cell proliferation and apoptosis. The pro-apoptosis gene Bax was up-regulated and suppression apoptosis Bcl-2 was significantly down regulated in the combination group. The expression of apoptosis associated proteins caspase-3 and caspase-9 in the combined administration group were obviously increased. Conclusion: Cinobufacini and cisplatin could significantly inhibit the proliferation and induce apoptosis of osteosarcoma cell, combination these two drugs had synergistic effect, its mechanism might be related to the activation of apoptosis pathway.
出处 《现代生物医学进展》 CAS 2017年第30期5812-5817,共6页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81341078) 中央高校基本科研业务费专项基金(2042017kf0163)
关键词 华蟾素 顺铂 U2OS 增殖 凋亡 Cinobufacini Cisplatin U2OS Proliferation Apoptosis
  • 相关文献

参考文献7

二级参考文献101

  • 1杨湘越.骨肉瘤实验室诊断研究现状及对策[J].中华临床医师杂志(电子版),2012,6(21):6841-6842. 被引量:8
  • 2牛晓辉,蔡槱伯,张清,郝林,丁易.ⅡB期肢体骨肉瘤189例综合治疗临床分析[J].中华外科杂志,2005,43(24):1576-1579. 被引量:41
  • 3郭卫,汤小东,唐顺,杨毅.三氧化二砷联合化疗治疗Ⅲ期成骨肉瘤、尤文肉瘤的初步报告[J].中华外科杂志,2006,44(12):805-808. 被引量:26
  • 4徐珊,徐昌芬.肿瘤多药耐药性发生机制及中药逆转作用的研究进展[J].中国肿瘤生物治疗杂志,2006,13(6):404-411. 被引量:39
  • 5W. Zhang,J. Qian,H. Yi,Z. Yang,C. Wang,J. Chen,X. Wei,Q. Fu,H. Ma.The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression[J]. Molecular Biology . 2012 (4)
  • 6Matthew L. Broadhead,Jonathan C. M. Clark,Damian E. Myers,Crispin R. Dass,Peter F. M. Choong,H. Kovar.The Molecular Pathogenesis of Osteosarcoma: A Review[J]. Sarcoma . 2011
  • 7J. W. Martin,M. Zielenska,G. S. Stein,A. J. van Wijnen,J. A. Squire,Stephen Lessnick.The Role of RUNX2 in Osteosarcoma Oncogenesis[J]. Sarcoma . 2010
  • 8Yin-He Wang,Jin Xiong,Shou-Feng Wang,Yang Yu,Bin Wang,Yi-Xin Chen,Hong-Fei Shi,Yong Qiu.Lentivirus-mediated shRNA targeting insulin-like growth factor-1 receptor (IGF-1R) enhances chemosensitivity of osteosarcoma cells in vitro and in vivo[J]. Molecular and Cellular Biochemistry . 2010 (1-2)
  • 9AikateriniBerdiaki,Georgios A.Datsis,DraganaNikitovic,AristidisTsatsakis,PavlosKatonis,Nikos K.Karamanos,George N.Tzanakakis.Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration[J]. IUBMB Life . 2010 (5)
  • 10Virna D. Leaner,Jeffrey F. Chick,Howard Donninger,Ilona Linniola,Arnulfo Mendoza,Chand Khanna,Michael J. Birrer.Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma[J]. The American Journal of Pathology . 2009 (1)

共引文献71

同被引文献86

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部